A Case of Neurofibromatosis 2 Presenting with a Mononeuritis Multiplex

Total Page:16

File Type:pdf, Size:1020Kb

A Case of Neurofibromatosis 2 Presenting with a Mononeuritis Multiplex Journal of Neurology, Neurosurgery, and Psychiatry 1992;55:391-393 391 SHORT REPORT J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.55.5.391 on 1 May 1992. Downloaded from A case of neurofibromatosis 2 presenting with a mononeuritis multiplex T J Kilpatrick, R J Hjorth, M F Gonzales Abstract forearm extensors. There was weakness of the A patient with neurofibromatosis 2 had an intrinsic muscles of the right hand and gener- asymmetrical peripheral neuropathy. A alised weakness of the left arm. The legs were nerve biopsy specimen revealed neuro- also wasted with symmetrical distal weakness. fibromatous changes, and the neuropathy The reflexes were depressed on the right but may have been a direct consequence of normal on the left, except for a depressed ankle neurofibromatosis. An apparent clinical jerk. The right plantar was flexor and the left response to immunosuppressive treat- unresponsive. There was a mild impairment of ment and plasma exchange is also repor- all sensory modalities in the hands and legs, ted. extending to the right knee and to the left anterior superior iliac spine. There were no palpable enlargements along the course of any The term neurofibromatosis defines two peripheral nerves. genetically and phenotypically distinct dis- The results of tests for urea, electrolytes and orders.' Neurofibromatosis 1, or von Reck- liver function, full blood examination and linghausen's disease, is an autosomal domi- random blood glucose and serum calcium, nant disorder with the genetic abnormality phosphate, vitamin B12, and folate concentra- localised to chromosome 17. Typical abnor- tions were all normal. There was no para- malities include cafe-au-lait spots, neuro- proteinaemia, antinuclear antibodies were not fibromas, and Lisch nodules in the iris. Neuro- detected and the erythrocyte sedimentation fibromatosis 2 is also an autosomal dominant rate was 27 mm in the first hour. Serological disorder, but the genetic abnormality is a tests for syphilis and HIV 1 yielded negative deletion on chromosome 22. The characteristic results. The CSF contained 5 x 106/1, the feature is bilateral acoustic neuromas, and loss glucose concentration was 3-8 mmol/l, and the of hearing is often the first symptom. Other protein was elevated at 1-39 g/l. Nerve conduc- CNS tumours, including meningiomas and tion studies showed mild slowing of the left gliomas, also occur. Cafe-au-lait spots and ulnar motor conduction velocity to 40 mls, and peripheral tumours, although less common the left median and ulnar and the right lateral http://jnnp.bmj.com/ than in neurofibromatosis 1, may also be popliteal nerve amplitudes were at the lower found.2 The tumours range from discrete limits of the normal ranges. The corresponding Schwannomas to poorly delineated plexiform F wave latencies were also mildly prolonged. neurofibromas.3 Even in neurofibromatosis 1, The ulnar, median, and left sural nerve sensory however, peripheral tumours are usually potentials were absent, but the right sural asymptomatic, with deficits occurring in only nerve action potential was preserved. A left 4-3% of cases in the series reported by Cannale sural nerve biopsy specimen showed loss of et al.4 some myelinated fibres without active axonal on September 29, 2021 by guest. Protected copyright. We have found there are five previous degeneration or demyelination. reports of peripheral neuropathy associated A provisional diagnosis of subacute, asym- with neurofibromatosis, and two of the cases metrical, sensorimotor peripheral neuropathy had neurofibromatosis 2.` We describe a was made. Although the nerve conduction further patient who had neurofibromatosis 2, studies did not show either a conduction block Royal Melbourne Hospital, Gratton the first to our knowledge to present initially or gross slowing ofthe conduction velocity, the Street, Parkville, with an asymmetrical sensorimotor neuro- clinical presentation and CSF findings sug- Victoria 3050, pathy and subsequently to develop more char- gested the possibility of an inflammatory Australia Department of acteristic features. demyelinating neuropathy, and the patient was Neurology treated with prednisolone (50mg/day). Two T J Kilpatrick months later, however, there had been progres- R J Hjorth Case report sion of symptoms and signs. Azathioprine was Department of A 24 year old male presented with four months started (100mg/day), and seven plasma Anatomical Pathology (Neuropathology of progressive peripheral numbness and weak- exchanges were given. Considerable clinical Laboratory) ness, beginning with paraesthesiae in the fin- improvement occurred over the next three M F Gonzales gers and weakness of the left foot, followed by months. In particular, the sensory deficit Correspondence to: the of truncal ataxia and multiple diminished, his ataxia resolved, and he was Dr Kilpatrick development Received 15 October 1990 falls. There was bilateral wasting of the peri- able to return to his previous employment. and in final revised form and intrinsic hand muscles and wast- Two years later he presented with a hoarse 25 June 1991. scapular Accepted 9 July 1991 ing of the left deltoid, brachioradialis, and voice, right tinnitus, and impaired vision in the 392 Kilpatrick, Hjorth, Gonzales right eye. There was a right fundal astrocytic S-l00 staining was performed and immuno- J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.55.5.391 on 1 May 1992. Downloaded from hamartoma. Examination also showed right reactivity was detected within the whorled lower motor neuron facial nerve, accessory structures comprising the endoneurial neuro- nerve, and vocal cord pareses and bilateral fibroma. The upper cervical tumour was sensorineural deafness. The pattern of weak- removed surgically and identified as a neuro- ness in the limbs was unchanged but in the legs fibroma by histopathology. At the operation, the sensory abnormalities were now confined numerous tumours on multiple cervical nerve to the feet. The ankle jerks were absent and roots were also detected. The patient made a both plantar responses were extensor. A good recovery after the operation cerebral CT scan showed multiple meningio- mata and bilateral acoustic neuromas. MRI of the cerebrum and cervical cord confirmed this and also revealed tumours on the second and Discussion seventh cervical nerve roots, the former caus- This patient initially presented with signs ing cervical cord compression. An MRI of the suggestive of an asymmetrical peripheral lower cord and the cauda equina was normal, neuropathy, and there was objective improve- with no evidence of tumours on the lumbar- ment after starting immunosuppressive treat- sacral nerve roots. A diagnosis of neuro- ment. The subsequent development of cranial fibromatosis 2 was made and, on review, small nerve palsies led to the identification of multi- cutaneous neurofibromas were found and con- ple central nervous system tumours and to the firmed histologically. There was no known ultimate diagnosis of neurofibromatosis 2. relevant family history. There are five previous reports of gener- The original sural nerve biopsy specimen alised neuropathy associated with neuro- was reviewed, and further sectioning detected fibromatosis but the clinical features, histo- changes in one fasciculus suggestive of a logical findings, and postulated pathogenetic neurofibroma (figure). As part of the review, mechanisms differ. Bradley et al reported a family with a predominantly motor axonal neuropathy resembling peroneal muscular atrophy, in which the propositus had neuro- fibromatosis 1. A sural nerve biopsy specimen revealed multiple tumours, but because one of ..; % ': \ -z; two daughters with subclinical neuropathy did .. not have clinical neurofibromatosis, the neuro- .k 1~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~.... logical deficits in the kindred were attributed to an unrelated neuronal degeneration. Bosch et /~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i al6 also described four patients, three from one family, with neurofibromatosis 1 and clinical features resembling peroneal muscular atrophy. Nerve biopsy specimens showed axo- nal degeneration and concentric Schwann cell hyperplasia but lacked classical neurofibroma- tous changes. The neuropathy was attributed http://jnnp.bmj.com/ to a primary neuronal degeneration with reac- tive Schwann cell proliferation. Ohnishi and Nada7 reported a patient with neurofibromatosis 2 and a six year history of a progressive, distal sensorimotor neuropathy. A nerve biopsy specimen showed large myeli- nated fibre loss and lamellated structures interpreted as areas of Schwann cell hyper- on September 29, 2021 by guest. Protected copyright. plasia. Thomas et al,8 however, reviewed the histology and suggested that these structures were of perineurial origin and characteristic of neurofibromatous changes, making a com- pressive cause for the neuropathy more likely. They also reported three further patients. The third had neurofibromatosis 2, palpable nerves, and presented with a six month history of a progressive and symmetrical sensorimotor neuropathy. Neurofibromas were identified on a nerve biopsy specimen in this patient, and the authors concluded that the neuropathy was the direct consequence of neurofibromatosis.8 Our case differs from the above reports in that an apparent asymmetrical peripheral neuropathy of subacute onset was the initial manifestation. Although individual subcuta- neous neurofibromas are often
Recommended publications
  • Anatomical Pathology Residency Program PROGRAM DESCRIPTION and OUTLINE – Non-CBME
    Anatomical Pathology Residency Program PROGRAM DESCRIPTION AND OUTLINE – Non-CBME The Anatomical Pathology Residency Program at the Schulich School of Medicine & Dentistry at Western University is a five year program based at the London Health Sciences Centre, University Hospital. There is a structured schedule of rotations designed to ensure that residents are able to fulfill all of the goals and objectives of training and acquire the necessary knowledge base to practice as competent consultant pathologists. There are also elective opportunities that permit the resident to tailor the program to their own needs and goals. There is a comprehensive education program, with various rounds and teaching sessions that supplement the rotations. Program Organization Rotations (4 week blocks) General Surgery 2 blocks General Internal Medicine 1 block Respirology or Nephrology 1 block Gynecologic Oncology 1 block Radiation Oncology 1 block Emergency Medicine 1 block PGY1 Urology 1 block Gastroenterology 1 block Hematology Oncology 1 block Anatomical Pathology 1 block Otolaryngology 1 block Pediatric Medicine 1 block The PGY1 year is a broad based clinical year designed to satisfy the specialty-specific objectives and Medical Council of Canada Qualifying Examination Part II requirements. Rotations are planned in conjunction with the resident in order to meet individual needs (the above-mentioned rotations may be changed). During this year, the resident attends the Pathology Academic Half Day, Department of Pathology Grand Rounds, and the Department
    [Show full text]
  • 2019-General-Pathology-Faq.Pdf
    FREQUENTLY ASKED QUESTIONS – 2019 Program: GENERAL PATHOLOGY Specialty/Field Questions: 1. a) What are some strengths about your specialty? What draws and keeps people in your specialty? • The opportunity to understand the nature of disease in an in-depth way that isn’t achieved in any other specialty. You get to practice scientific diagnostic medicine over a broad range of subjects and you have a fair degree of control over your schedule. You are very much a part of the team taking care of the patient (it just isn’t as obvious!), and this is becoming even more apparent in the era of precision medicine. • Although there is limited direct contact with patients, there is a great deal of contact with a variety of clinicians outside the laboratory as well as with physician, PhD, and technical staff colleagues within the laboratory. We get satisfaction from the interactions we have with others, and knowing that we are helping a clinician take the next step in diagnosing or treating a patient. The stereotypical image of the hermit- like pathologist who stays in their office and never talks to anyone is rapidly disappearing in today’s pathology practice. b) What are some common complaints about your specialty? • There is limited direct clinical contact – you’ll never have an office full of patients who regard you as their doctor and most pathologists have a hospital-based practice which can limit professional autonomy. • You often have to sit/stand at a microscope and/or computer a lot, so sometimes you need to get creative about staying active during the day.
    [Show full text]
  • Anatomical Pathology
    Timely and accurate pathology results are Pathology disciplines critical to the functioning of our entire medical system. 70% of all diagnoses are made using a pathology test. All chronic conditions require monitoring via pathology testing. Pathologists play a Pathology informs the clinical decisions of medical practitioners much wider role than just diagnosing cancer, and work across a range across the healthcare spectrum. of different specialities, in addition to anatomical pathology. These include: Given its critical role, the risks of not adequately supporting Pathologists are Indispensable to Quality Patient Care a strong national pathology system are: Chemical pathology, which deals with the entire range of disease, • Incorrect diagnoses; and encompasses detecting changes in a number of substances in • Delayed diagnoses; blood and body fluids (such as electrolytes, enzymes and proteins); • Patients receiving incorrect treatment; Forensic pathology, which seeks to investigate and define the cause • Tumours inadequately or inappropriately treated (e.g. of unexpected death; unnecessary surgery); and Genetics, which looks at chromosomes and DNA from cells to • Possible early patient death. diagnose genetic diseases; These issues may impact upon the physical, emotional and Haematology, which deals with diseases that affect the blood such as financial well-being of individual patients, their families and the anaemia, leukaemia, lymphoma, clotting or bleeding disorders as well community at large. as management of blood transfusions; Immunopathology, which deals with the diagnosis and management As the peak body representing the profession, the RCPA of conditions in which the immune system does not function properly; believes the underlying principles of a world class pathology service are: Microbiology, which deals with diseases caused by infectious agents • A commitment to patient safety and quality such as bacteria, viruses, fungi and parasites; and • A highly trained and sufficiently resourced workforce General pathology, which covers the profession as a whole.
    [Show full text]
  • Quality Assurance Program for Anatomical Pathologists Printed Copies Are Uncontrolled
    Quality Assurance Assessment Program for Anatomical Pathologists This provincial best practice document is being developed in response to the Cochrane Report recommending a peer review program for pathology with results reported to the Health Authority Quality Committee, BC’s Agency for Pathology and Laboratory Medicine and the Diagnostic Accreditation Program, when appropriate. The program has been developed with input from the provincial Anatomic Pathology Working Group, along with review of current provincial practices and peer reviewed publications, specifically the Pan- Canadian Quality Assurance Recommendations for Interpretive Pathology. The program is designed to be proactive where quality activities are embedded directly into the clinical practice of anatomic pathologists via the Laboratory Information System (LIS), allowing standardized quality assurance data to be captured, reported, reviewed and discrepancies reported for follow up corrective action through standardized quality improvement processes. Objective: Develop a standardized approach to Quality Assurance (QA) in interpretive pathology for use by all anatomic pathologists. Capture pathologist QA activities, and provide meaningful statistics to individual pathologists, the Laboratory quality committee, health authority medical administration and the Agency to allow year over year comparisons by pathologist, facility, HA and comparisons across the province. To build a provincial anatomic pathology culture based on sustainable high quality diagnostic services to enable the enhancement of patient safety. To ensure the public have confidence in British Columbia’s anatomic pathology service regardless of geographic location or jurisdiction. Goal: For the activities related to all anatomic pathologists caseload be involved in a review, which is measurable and comparable to a standard baseline. Where appropriate, reviews will target surgical pathology, cytology and autopsy services, including all related ancillary testing.
    [Show full text]
  • Specialty Training Requirements in Anatomical Pathology
    Specialty Training Requirements in Anatomical Pathology 2013 EDITORIAL REVISION 2016 VERSION 2.1 These training requirements apply to those who begin training on or after July 1st, 2013. MINIMUM TRAINING REQUIREMENTS Five (5) years of accredited residency training. This period must include: Basic Clinical Training 1. Thirteen (13) blocks of basic clinical training relevant to Anatomical Pathology. This period must include: 1.1. Two (2) blocks in a surgical specialty 1.2. Two (2) blocks in Internal Medicine, including General Internal Medicine or other subspecialties 1.3. One (1) block in Pediatrics or a pediatric subspecialty 1.4. One (1) block in Obstetrics and Gynecology or a subspecialty thereof 1.5. One (1) block in an oncologic specialty 1.6. Six (6) blocks of further basic clinical training as approved by the program director Core Anatomical Pathology 2. Forty (40) blocks of approved residency training in Anatomical Pathology. These forty (40) blocks must include a minimum of: 2.1. Twenty-five (25) blocks or equivalent longitudinal experience in surgical pathology and adult autopsy pathology 2.2. One (1) block or equivalent longitudinal experience in molecular pathology and cytogenetics 2.3. Two (2) blocks or equivalent longitudinal experience in forensic pathology 2.4. Four (4) blocks or equivalent longitudinal experience in cytopathology, one (1) of which must be completed in final year 2.5. Two (2) blocks or equivalent longitudinal experience in pediatric pathology 2.6. Two (2) blocks or equivalent longitudinal experience in neuropathology © 2013 The Royal College of Physicians and Surgeons of Canada. All rights reserved. This document may be reproduced for educational purposes only, provided that the following phrase is included in all related materials: Copyright © 2013 The Royal College of Physicians and Surgeons of Canada.
    [Show full text]
  • Frequently Asked Questions: Anatomic Pathology and Clinical
    Frequently Asked Questions: Anatomic Pathology and Clinical Pathology (FAQs related to Pathology Program Requirements effective July 1, 2020) Review Committee for Pathology ACGME Question Answer Introduction Can residents leave in the middle of their Yes, as the American Board of Pathology allows residents to enter a pathology program to complete a fellowship and then fellowship program (except dermatopathology) after 24 months of residency, the return to finish their pathology residency? Review Committee allows this as well. The expectation is that once the fellowship is completed, residents return to the pathology residency program to complete their [Program Requirement: Int.C.1.] education. Programs do not need to notify the Review Committee or request exceptions for residents to pursue this pathway. In the Accreditation Data System (ADS) these residents should be listed as “In Program but Doing Research/Other Training ”while they are in a fellowship program, and reset to “Active Full time” status once the fellowship is completed and they have returned to the pathology residency program. If a resident wishes to focus only on No. All pathology programs are accredited as APCP-4, with anatomic pathology only anatomic pathology or clinical pathology, (AP-3) and clinical pathology only (CP-3) offered as tracks within the program, not as must the Sponsoring Institution apply for a separately accredited programs. There is no separate application process, as separate program or does the existing programs are free to offer these tracks to residents if they choose. The Educational program need any other approval from the Program section of the Program Requirements clearly denotes tracks so that programs Review Committee? can understand the expectations for residents in any of the tracks.
    [Show full text]
  • Curriculum Vitae
    Prepared: November 20, 2019 University of California, San Francisco CURRICULUM VITAE Name: Elham Khanafshar, MD, MS Position: Professor of Clinical Pathology, Step 2 Pathology School of Medicine Address: Box 1785 1600 Divisadero St.,MZ Bldg B, R207 University of California, San Francisco San Francisco, CA 94143 Voice: 415-353-7380 Email: [email protected] EDUCATION 1989 - 1997 Tehran University of Medical M.D. Sciences, Tehran, Iran 1997 - 1999 University of Southern California, M.S. Molecular & Experimental Los Angeles, CA Pathology 1999 - 2002 Cedars-Sinai Medical Center, Los Resident Anatomical & Clinical Angeles, CA Pathology 2002 - 2003 Cedars-Sinai Medical Center, Los Chief Resident Anatomical & Clinical Angeles, CA Pathology 2003 - 2004 University of California, San Fellow Surgical Pathology Diego, CA 2004 - 2005 University of Southern California, Fellow Cytopathology Los Angeles, CA 2007 - 2007 University of Toronto, Toronto, Visiting Endocrine Pathology ON Canada Pathologist 2010 - 2010 University of Wisconsin, Visiting Endocrine Pathology Minnesota, WI Pathologist LICENSES, CERTIFICATION 2001 Medical licensure, California 2003 Anatomical and Clinical Pathology Board Certification 2005 Cytopathology Board Certification 2005 Thin-Prep Certification 1 of 31 Prepared: November 20, 2019 2006 ImmunoCyt Certification 2016 UCSF Bilingual Clinician Certification 2019 American Heart Association Basic Life Support PRINCIPAL POSITIONS HELD 2002 - 2003 Cedars-Sinai Medical Center, Los Angeles, Chief Resident Anatomic and CA Clinical
    [Show full text]
  • BASIC PATHOLOGY DEFINITIONS Pathology  the Study of Disease
    BASIC PATHOLOGY DEFINITIONS Pathology the study of disease. Pathology is a medical specialty studying disease processes, how they develop and what they are caused by and the application of this knowledge to the diagnosis of disease. Pathos= "disease" Logos= "a treatise/ a study" Anatomical pathology is a medical specialty that is concerned with the diagnosis of disease based on the macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues. Lesions are recognizable morphologic (anatomic) changes in tissues, either grossly or microscopically. Clinical pathology determines diagnosis of disease through the study of body fluids and body waste products. These include blood plasma, urine, cerebrospinal fluid, sputum', saliva, peritoneal fluid, thoracic fluid, and feces. Animal Biopsy Necropsy Necropsy a postmortem examination of a body after death or autopsy. At its core, it is the systematic dissection and examination of an animal carcass to search for abnormal anatomical changes (lesions) in the tissues. NECROPSY Necropsy, necroscopy (Gr.): examination of a body after death Necro= dead body Opsis= a sight, view AUTOPSY Autopsy (Gr.): to see with one's own eyes Auto=self, one's own Opsis= a sight, view OBDUCTION Obduction opening of the dead. It is mostly used for the FORENSIC pathology. DISSECTION Section mostly used for the, a slice of tissue in anatomy. Dissection is the dismembering of the body of a deceased animal or plant to study its anatomical structure. BIOPSY Biopsy an examination of tissue removed from a living body to discover the presence, cause, or extent of a disease. Biopsy (Gr.): view of the living" or "appearance of life.
    [Show full text]
  • Pathology and Laboratory Medicine Service
    PG-18-9 – SPACE PLANNING CRITERIA October 1, 2021 240 – Pathology and Laboratory Medicine Service CHAPTER 240: PATHOLOGY AND LABORATORY MEDICINE SERVICE 1 PURPOSE AND SCOPE .................................................................................................. 240-2 2 DEFINITIONS ................................................................................................................ 240-2 3 OPERATING RATIONALE AND BASIS OF CRITERIA .......................................................... 240-5 4 INPUT DATA STATEMENTS (IDS) ................................................................................... 240-7 5 SPACE PLANNING CRITERIA - MEDICAL CENTER LABORATORY ....................................... 240-8 6 SPACE PLANNING CRITERIA - OUTPATIENT CLINIC LABORATORY ................................. 240-27 7 PLANNING AND DESIGN CONSIDERATIONS ................................................................. 240-27 8 FUNCTIONAL RELATIONSHIPS..................................................................................... 240-30 9 FUNCTIONAL DIAGRAM ............................................................................................. 240-31 1 of 31 PG-18-9 – SPACE PLANNING CRITERIA October 1, 2021 240 – Pathology and Laboratory Medicine Service 1 PURPOSE AND SCOPE This document outlines the space planning criteria for Chapter 240: Pathology and Laboratory Medicine Service (PMLS). It applies to all medical facilities at the Department of Veterans Affairs (VA). Department of Veterans Affairs (VA) Medical Center
    [Show full text]
  • Anatomical Pathology - Trainee Handbook
    Anatomical Pathology - Trainee Handbook @ TRAINEE HANDBOOK 2021 Anatomical Pathology It is essential to read this Handbook in conjunction with the Trainee Handbook – Administrative Requirements which is relevant to all trainees. This has information about the College’s structure and policies, together with details of requirements for registration, training and examination applications. © January 2021 Royal College of Pathologists of Australasia TABLE OF CONTENTS GLOSSARY ..................................................................................................................................... i Section 1 ......................................................................................................................................... 1 Introduction ..................................................................................................................................... 1 Personal characteristics needed ..................................................................................................... 1 General aims of the training program .............................................................................................. 1 Training requirements ..................................................................................................................... 2 Supervision ..................................................................................................................................... 3 Assessment ...................................................................................................................................
    [Show full text]
  • Objectives of Training in the Specialty of Anatomical Pathology
    Objectives of Training in the Specialty of Anatomical Pathology 2010 VERSION 1.0 This document applies to those who begin training on or after July 1st, 2010. (Please see also the “Policies and Procedures.”) DEFINITION Anatomical Pathology is that branch of laboratory medicine concerned with the study of the morphologic aspects of disease. It includes the subdomains of cytopathology, gynecological pathology, dermatopathology, gastrointestinal pathology, cardiovascular pathology, respiratory pathology, musculoskeletal pathology, renal pathology, genito-urinary pathology, endocrine pathology, ophthalmic pathology, head and neck pathology, neuropathology, pediatric pathology, forensic pathology, and certain laboratory methods such as immunohistochemistry, immunofluorescence, in-situ hybridization, flow cytometry, molecular pathology, electron microscopy. GOALS Upon completion of training, a resident is expected to be a competent specialist in Anatomical Pathology capable of assuming a consultant’s role in the specialty. The resident must acquire a working knowledge of the theoretical basis of the specialty, including its foundations in the basic medical sciences and research. Residents must demonstrate the requisite knowledge, skills, and attitudes for effective patient-centered care and service to a diverse population. In all aspects of specialist practice, the graduate must be able to address issues of gender, sexual orientation, age, culture, ethnicity and ethics in a professional manner. ANATOMICAL PATHOLOGY COMPETENCIES At the completion of training, the resident will have acquired the following competencies and will function effectively as a: © 2010 The Royal College of Physicians and Surgeons of Canada. All rights reserved. This document may be reproduced for educational purposes only provided that the following phrase is included in all related materials: Copyright © 2010 The Royal College of Physicians and Surgeons of Canada.
    [Show full text]
  • Chapter 1 General Pathology
    Chapter 1: General Pathology Chapter 1 General Pathology Chapter Outline: Introduction Metaplasia General Objectives Cells on disease Type and calcification of the disease Necrosis Etiology of disease Apoptosis Methods and diagnosis of treatment Inflamed Specific objectives Etiology Blood Pathogenesis Respiratory system Morphologies changes Cardiovascular system Functional derangements and GIT system clinical significance Urinary system Distribution of lesions Endocrine system Local Locomotors system Focal CNS system Diffuse The core aspect of disease in pathology Diagnosis Environmental factor Therapy Genetic factor Prognosis Cellar reaction to injury Causes of disease Types of cellular Adaptations Environmental Hypertrophy Genetic factor Atrophy Cellular reaction to injury Hyperplasia Hyper atrophy 1 Pathology Atrophy Loss of function Hyperplasia Events of acute inflammation Metaplasia Vascular change Cells on disease Cellular event Necrosis Causes of acute inflammation Apoptosis Resolution Causes of inflammation Healing by fibrosis Physical agent Abscess formation Chemical agent Sinus formation Biological agent Fistula formation Immunological disorder Causes of chronic inflammation Genetic and metabolic disorder Persistent infection Cardinal sign of inflammation Prolonged exposure Redness Progression from acute inflammation Swelling Autoimmunity Pain 1.1. Introduction Pathology (from the Greek roots of pathos, meaning “experience” or “suffering”, and -logia, “study of”) is a significant component of the causal study of disease and a major field in modern medicine and diagnosis. The term pathology itself may be used broadly to refer to the study of disease in general, incorporating a wide range of bioscience research fields and medical prac- tices (including plant pathology and veterinary pathology), or more narrowly to de- scribe work within the contemporary medical field of “general pathology”, which includes a number of distinct but inter-related medical specialties that diagnose dis- ease—mostly through analysis of tissue, cell, and body fluid samples.
    [Show full text]